Maureen Dubreuil MD, MSc.
Assistant Professor, Rheumatology
650 Albany St | (617) 638-5180maureen.dubreuil@bmc.org
mdubreui@bu.edu
Sections
Rheumatology
Centers
Arthritis & Autoimmune Diseases Research Center
Biography
Dr. Dubreuil is a rheumatologist in Boston, specializing in Spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. In 2013, she was awarded the Arthritis Foundation Clinical to Research Transition Award and 2016, she began work on a K23-funded project to study patient preferences, and the cost-effectiveness of treatment modalities for spondyloarthritis, to inform both clinical care and policy decisions. She serves as Education Chair and Board Member for the Spondyloarthritis Research and Treatment Network (SPARTAN), is a Medical Advisor for the Spondylitis Association of America, and is a member of the Assessment of Spondyloarthritis International Society (ASAS). She is a site investigator for the international CLASSIC study and the PULSAR spondyloarthritis registry.
Websites
Dr. Dubreuil's publications on PubMed
Rheumatology Faculty at BU Medical Center
Boston Medical Center Provider Profile
VA Boston Healthcare System Rheumatology Clinic
American College of Rheumatology Abstracts by Dr. Dubreuil
ACR On Air Podcast Episode: Treating Spondyloarthritis
BU Rheumatology Fellowship Program Video
An interview on WebMD about Ankylosing Spondylitis
Dr. Dubreuil's profile on LinkedIn
Education
Medicine-Internal, MD, University of Connecticut School of Medicine
MSc, Boston University School of Public Health
Biology, BS, Rochester Institute of Technology
Publications
Dubreuil M. Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings. Curr Rheumatol Rep. 2024 Feb 10. PMID: 38340269.
Published on 2/6/2024Jinno S, Onishi A, Hattori S, Dubreuil M, Ueda Y, Nishimura K, Okano T, Yamada H, Yamamoto W, Murata K, Onizawa H, Ebina K, Maeda Y, Son Y, Amuro H, Hara R, Hata K, Shiba H, Katayama M, Watanabe R, Hashimoto M, Saegusa J. Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study. Rheumatology (Oxford). 2024 Feb 06. PMID: 38317442.
Published on 9/21/2023Bittar M, Nouer SS, Tolley EA, Dubreuil M, Magrey M. Mortality and Ankylosing Spondylitis in the US population: leading causes and associated factors. Clin Rheumatol. 2024 Jan; 43(1):227-232. PMID: 37733078.
Published on 9/7/2023George N, Liew JW, Dubreuil M. The role of upadacitinib for the treatment of axial spondyloarthritis. Immunotherapy. 2023 Oct; 15(15):1227-1237. PMID: 37675498.
Published on 8/22/2023Merjanah S, Liew JW, Bihn J, Fillmore NR, Brophy MT, Do NV, Dubreuil M. Trends in Fracture Rates Over Two Decades Among Veterans With Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2023 Dec; 75(12):2481-2488. PMID: 37308459.
Published on 4/10/2023Beaudette-Zlatanova B, Lew RA, Otis JD, Branch-Elliman W, Bacorro E, Dubreuil M, Eyvazzadeh C, Kaur M, Lazzari AA, Libbey C, Monach PA. Pilot Study of Low-dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-controlled, Crossover Clinical Trial. Clin Ther. 2023 May; 45(5):468-477. PMID: 37045708.
Published on 2/23/2023Kumar D, Neogi T, Peloquin C, Marinko L, Camarinos J, Aoyagi K, Felson DT, Dubreuil M. Delayed timing of physical therapy initiation increases the risk of future opioid use in individuals with knee osteoarthritis: a real-world cohort study. Br J Sports Med. 2023 Aug; 57(15):958-964. PMID: 36822841.
Published on 2/14/2023Machado PM, Schäfer M, Mahil SK, Liew J, Gossec L, Dand N, Pfeil A, Strangfeld A, Regierer AC, Fautrel B, Alonso CG, Saad CGS, Griffiths CEM, Lomater C, Miceli-Richard C, Wendling D, Alpizar Rodriguez D, Wiek D, Mateus EF, Sirotich E, Soriano ER, Ribeiro FM, Omura F, Rajão Martins F, Santos H, Dau J, Barker JN, Hausmann J, Hyrich KL, Gensler L, Silva L, Jacobsohn L, Carmona L, Pinheiro MM, Zelaya MD, Severina MLÁ, Yates M, Dubreuil M, Gore-Massy M, Romeo N, Haroon N, Sufka P, Grainger R, Hasseli R, Lawson-Tovey S, Bhana S, Pham T, Olofsson T, Bautista-Molano W, Wallace ZS, Yiu ZZN, Yazdany J, Robinson PC, Smith CH. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Ann Rheum Dis. 2023 May; 82(5):698-709. PMID: 36787993.
Published on 1/10/2023Kwan YH, Phang JK, Woon TH, Liew JW, Dubreuil M, Proft F, Ramiro S, Molto A, Navarro-Compán V, de Hooge M, Meghnathi B, Ziade N, Zhao SS, Llop M, Baraliakos X, Fong W. Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. J Med Internet Res. 2023 Jan 10; 25:e39155. PMID: 36626201.
Published on 7/30/2022Liew JW, Dubreuil M. Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis. Lancet. 2022 Jul 30; 400(10349):340-341. PMID: 35908562.
Media Mentions
Published on 11/15/2023
First Referral Guide Issued for Axial Spondyloarthritis
Published on 6/16/2022
The Consumer’s Guide to JAK Inhibitors for Ankylosing Spondylitis
Published on 2/15/2022
How to Tell Psoriatic Arthritis vs. Rheumatoid Arthritis Apart
Published on 12/21/2021
How medicine erased Black women from a ‘white man’s disease’
Published on 11/19/2018
Case Report: Acne Drug Leads Patient to Retinoid Hyperostosis
View full list of 5 media mentions.